What are the major opportunities in the Idefirix market? What are the strategies for the Idefirix market?

For detailed insights on the major opportunities and strategies in the Idefirix market, Read More

How does the Idefirix market relate to the overall economy and other similar markets?

For detailed insights on Idefirix's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Idefirix market growth? SWOT analysis of the Idefirix market.

For detailed insights on the key dynamics influencing the Idefirix market growth and SWOT analysis of the Idefirix industry, Read More

Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Idefirix Global Market Report 2025

Name: Idefirix Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Patient Demographics (Pediatric Patients, Adult Patients), By Application (Kidney Transplantation, Desensitization Protocols), By End-User (Hospitals, Specialized Clinics, Home Healthcare), By Distribution Channel (Direct Sales, Pharmacies)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Idefirix Market?

Idefirix (imlifidase) is an enzyme-based medication designed to reduce donor-specific antibodies in highly sensitized kidney transplant patients, enabling successful organ transplantation. It is used to desensitize patients awaiting kidney transplants by cleaving IgG antibodies, increasing compatibility with available donors.

The main patient demographics of Idefirix are pediatric patients and adult patients. Pediatric patients are children or adolescents who require medical care tailored to their developmental and physiological needs. It is used in applications such as kidney transplantation and desensitization protocols. The end users of Idefirix are hospitals, specialized clinics, and Home Healthcare. It is distributed through distribution channels such as direct sales and pharmacies.

Idefirix Market Size and growth rate 2025 to 2029: Graph

What Is The Idefirix Market Size 2025 And Growth Rate?

The idefirix market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increased incidence of allergic diseases, increased doses of the drug, increased prevalence of chronic diseases, a rise in demand for organ transplants, and increased prevalence and incidence of kidney diseases.

What Is The Idefirix Market Growth Forecast?

The idefirix market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing kidney waiting list volumes, increasing awareness regarding organ donation, increasing research and development, rising number of procedures and FDA approvals, and rising awareness of antibody-mediated rejection. Major trends in the forecast period include advancements in antibody-cleaving enzyme technology, increasing investments in transplant immunology research, collaboration with transplant centers for clinical integration, a growing focus on personalized medicine, and government initiatives for organ transplantation.

Book your 30 minutes free consultation with our research experts

How Is The Idefirix Market Segmented?

The idefirix market covered in this report is segmented –

1) By Patient Demographics: Pediatric Patients, Adult Patients

2) By Application: Kidney Transplantation, Desensitization Protocols

3) By End-User: Hospitals, Specialized Clinics, Home Healthcare

4) By Distribution Channel: Direct Sales, Pharmacies

What Is Driving The Idefirix Market? Rising Prevalence and Incidence of Kidney Diseases Fueling Idefirix Market Growth

The increasing prevalence and incidence of kidney diseases is expected to propel the growth of the idefirix market going forward. Kidney diseases are conditions that damage the kidneys' function or structure, hindering their ability to filter waste and maintain fluid balance in the body. The increasing prevalence and incidence of kidney diseases can be attributed to factors such as an aging population, rising rates of diabetes and hypertension, lifestyle choices, and genetic predispositions. Idefirix, a groundbreaking immunoglobulin G (IgG)-degrading enzyme therapy, helps kidney disease patients by enabling highly sensitized individuals to undergo life-saving kidney transplants by effectively reducing donor-specific antibodies that would otherwise cause transplant rejection. For instance, in June 2023, according to a report published by the kidney research, a UK-based research organization, the incidence of acute kidney injury is projected to increase from an estimated 615,000 cases in 2022 to 637,000 by 2033. Therefore, increasing prevalence and incidence of kidney diseases is driving the growth of the idefirix market.

Who Are The Major Players In The Global Idefirix Market?

Major companies operating in the idefirix market include Hansa Biopharma AB

What Are The Key Trends Of The Global Idefirix Market? Growing Innovation In Desensitization Treatments For Highly Sensitized Kidney Transplant Patients

The key trend in the idefirix market is focusing on developing innovative solutions, such as desensitization treatment, to desensitize highly sensitized kidney transplant patients. Desensitization treatment is a medical procedure that removes or reduces harmful antibodies, enabling transplant patients to receive organs from incompatible donors. For instance, in July 2023, Hansa Biopharma, a Sweden-based biopharmaceutical company, announced that the Australian Therapeutic Goods Administration (TGA), an Australia-based regulatory authority, approved Idefirix (imlifidase) as a desensitization treatment for highly sensitized kidney transplant patients. This approval enables these patients to receive kidney transplants from both living and deceased donors. The treatment works by reducing or removing harmful anti-donor antibodies, which can otherwise prevent transplantation. Based on positive results from Hansa Biopharma's phase 2 studies, this approval marks a significant step in improving kidney transplant options for highly sensitized patients in Australia.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Idefirix Market? Hansa Biopharma And Askbio Partner To Evaluate Imlifidase As Pre-Treatment For Pompe Disease Gene Therapy

In January 2022, Hansa Biopharma AB, a Sweden-based biopharmaceutical company partnered with Asklepios Biopharmaceutical Inc. (AskBio) to evaluate imlifidase as a pre-treatment for pompe disease gene therapy. The purpose of the partnership between Hansa Biopharma and AskBio is to evaluate the feasibility of using Imlifidase (Idefirix) as a pre-treatment for patients with neutralizing antibodies (NAbs) to adeno-associated virus (AAV) undergoing gene therapy for Pompe disease. This collaboration aims to address a significant challenge in gene therapy by overcoming antibody-mediated barriers, enabling successful treatment outcomes. Asklepios Biopharmaceutical (AskBio) is a UK-based gene therapy company that focuses on developing medicines using adeno-associated virus (AAV) vectors for genetic diseases.

Regional Analysis For The Global Idefirix Market

Europe was the largest region in the idefirix market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the idefirix market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the idefirix market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada

What Defines the Idefirix Market?

The idefirix market consists of sales of lyophilized powders and injectable solutions. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Idefirix Industry?

The idefirix market research report is one of a series of new reports from The Business Research Company that provides idefirix market statistics, including idefirix industry global market size, regional shares, competitors with a idefirix market share, detailed idefirix market segments, market trends and opportunities, and any further data you may need to thrive in the idefirix industry. This idefirix market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Idefirix Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included !
Revenue Forecast In 2034	Included !
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Patient Demographics: Pediatric Patients, Adult Patients 2) By Application: Kidney Transplantation, Desensitization Protocols 3) By End-User: Hospitals, Specialized Clinics, Home Healthcare 4) By Distribution Channel: Direct Sales, Pharmacies
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Hansa Biopharma AB
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Idefirix Market Characteristics

3. Idefirix Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Idefirix Market Trends And Strategies

5. Idefirix Market -Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Idefirix Growth Analysis And Strategic Analysis Framework

6.1. Global Idefirix PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Idefirix Market Growth Rate Analysis

6.4. Global Idefirix Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Idefirix Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Idefirix Total Addressable Market (TAM)

7. Global Idefirix Pricing Analysis & Forecasts

8. Idefirix Market Segmentation

8.1. Global Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Pediatric Patients

Adult Patients

8.2. Global Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Kidney Transplantation

Desensitization Protocols

8.3. Global Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospitals

Specialized Clinics

Home Healthcare

8.4. Global Idefirix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Direct Sales

Pharmacies

9. Global Idefirix Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Idefirix Market Regional And Country Analysis

10.1. Global Idefirix Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Idefirix Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Idefirix Market

11.1. Asia-Pacific Idefirix Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Idefirix Market

12.1. China Idefirix Market Overview

12.2. China Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Idefirix Market

13.1. India Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Idefirix Market

14.1. Japan Idefirix Market Overview

14.2. Japan Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Idefirix Market

15.1. Australia Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Idefirix Market

16.1. South Korea Idefirix Market Overview

16.2. South Korea Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Idefirix Market

17.1. Western Europe Idefirix Market Overview

17.2. Western Europe Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Idefirix Market

18.1. UK Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Idefirix Market

19.1. Germany Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Idefirix Market

20.1. France Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Idefirix Market

21.1. Eastern Europe Idefirix Market Overview

21.2. Eastern Europe Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Idefirix Market

22.1. North America Idefirix Market Overview

22.2. North America Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Idefirix Market

23.1. USA Idefirix Market Overview

23.2. USA Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Idefirix Market

24.1. Canada Idefirix Market Overview

24.2. Canada Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Idefirix Market

25.1. South America Idefirix Market Overview

25.2. South America Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Idefirix Market

26.1. Middle East Idefirix Market Overview

26.2. Middle East Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Idefirix Market

27.1. Africa Idefirix Market Overview

27.2. Africa Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Idefirix Market Competitive Landscape And Company Profiles

28.1. Idefirix Market Competitive Landscape

28.2. Idefirix Market Company Profiles

28.2.1. Hansa Biopharma AB Overview, Products and Services, Strategy and Financial Analysis

29. Global Idefirix Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Idefirix Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Idefirix Market

32. Recent Developments In The Idefirix Market

33. Idefirix Market High Potential Countries, Segments and Strategies

33.1 Idefirix Market In 2029 - Countries Offering Most New Opportunities

33.2 Idefirix Market In 2029 - Segments Offering Most New Opportunities

33.3 Idefirix Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Idefirix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Idefirix Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Global Idefirix Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Asia-Pacific, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: Asia-Pacific, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: China, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: China, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: India, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: India, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: Japan, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Japan, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Australia, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: Australia, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: South Korea, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: South Korea, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: Western Europe, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: Western Europe, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: UK, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: UK, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: Germany, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: Germany, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: France, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: France, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: Eastern Europe, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: Eastern Europe, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: North America, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: North America, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: USA, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: USA, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: Canada, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: Canada, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: South America, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: South America, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: Middle East, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Middle East, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Africa, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: Africa, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 60: Hansa Biopharma AB Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Idefirix Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Idefirix Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Global Idefirix Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Asia-Pacific, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: Asia-Pacific, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: China, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: China, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: India, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: India, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: Japan, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Japan, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Australia, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: Australia, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: South Korea, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: South Korea, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: Western Europe, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: Western Europe, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: UK, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: UK, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: Germany, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: Germany, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: France, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: France, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: Eastern Europe, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: Eastern Europe, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: North America, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: North America, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: USA, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: USA, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: Canada, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: Canada, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: South America, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: South America, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: Middle East, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Middle East, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Africa, Idefirix Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Idefirix Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: Africa, Idefirix Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 60: Hansa Biopharma AB Financial Performance

Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Drugs Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation

Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

$8.21 Billion Forecast for Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market by 2029, Backed by Demand and Innovation

Fentanyl Market Forecast Reaching $22.03 Billion by 2029 at 6.5% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By ...

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

Genito-Urinary Drugs Global Market Report 2022 – By Type (Hormonal Contraceptives, Drugs For Benign Prostatic hypertrophy, Drugs For Infertility, Drugs For Erectile Dysfunction, Drugs For Urinary Incontinence And Overact...

Oncology Drugs Global Market Report 2022 – By Type (Lung Cancer Drugs, Pancreatic Cancer Drugs, Breast Cancer Drugs, Prostate Cancer Drugs, Ovarian Cancer Drugs, Colorectal Cancer Drugs, Gastric Cancer Drugs, Kidney Canc...

Ophthalmology Drugs Global Market Report 2022 – By Type (Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)), By Distribution Channel (Hospital Pharmacies, R...

Frequently Asked Questions

What is the definition of the Idefirix market?

How will the Idefirix market drivers and restraints affect the market dynamics? What forces will shape the Idefirix industry going forward?

The Idefirix market major growth driver - Rising Prevalence and Incidence of Kidney Diseases Fueling Idefirix Market Growth. For further insights on the Idefirix market, request a sample here

What is the forecast market size or the forecast market value of the Idefirix market?

The Idefirix market size has grown strongly in recent years. The idefirix market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increased incidence of allergic diseases, increased doses of the drug, increased prevalence of chronic diseases, a rise in demand for organ transplants, and increased prevalence and incidence of kidney diseases. The idefirix market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing kidney waiting list volumes, increasing awareness regarding organ donation, increasing research and development, rising number of procedures and FDA approvals, and rising awareness of antibody-mediated rejection. Major trends in the forecast period include advancements in antibody-cleaving enzyme technology, increasing investments in transplant immunology research, collaboration with transplant centers for clinical integration, a growing focus on personalized medicine, and government initiatives for organ transplantation. For further insights on the Idefirix market, request a sample here

How is the Idefirix market segmented?

The idefirix market covered in this report is segmented –
1) By Patient Demographics: Pediatric Patients, Adult Patients
2) By Application: Kidney Transplantation, Desensitization Protocols
3) By End-User: Hospitals, Specialized Clinics, Home Healthcare
4) By Distribution Channel: Direct Sales, Pharmacies For further insights on the Idefirix market, request a sample here

Which region has the largest share of the Idefirix market? What are the other regions covered in the report?

Who are the major players in the Idefirix market?

Major companies operating in the idefirix market include Hansa Biopharma AB . For further insights on the Idefirix market, request a sample here.

What are the key trends in the Idefirix market?

Major trends in the Idefirix market include Growing Innovation In Desensitization Treatments For Highly Sensitized Kidney Transplant Patients. For further insights on the Idefirix market, request a sample here.